Business
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis. The combined portfolio delivers new insights for precision diagnostics, targeted therapeutics development, and understanding
About this update from Illumina, Inc.
[{"type":"text","content":"At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions","length":100,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis. The combined portfolio delivers new insights for precision diagnostics, targeted therapeutics development, and understanding of tumor microenvironments.","length":572,"tagName":"p"},{"type":"image","alt":"Left to right: Steve Barnard, PhD, Bodour Salhia, PhD, Jacob Thaysen, PhD, Marcel R. Nelen, PhD, Cande Rogert, PhD, Carrie Cibulskis, Sami Farhi, PhD","displaySize":"","headline":null,"caption":"Left to right: Steve Barnard, PhD, Bodour Salhia, PhD, Jacob Thaysen, PhD, Marcel R. Nelen, PhD, Cande Rogert, PhD, Carrie Cibulskis, Sami Farhi, PhD","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":225,"url":"https://media.zenfs.com/en/prnewswire.com/3aba75c94c9a7552a87779cae2d26353"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9mdDj_kR7C0cYZs4aFDz4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM5NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3aba75c94c9a7552a87779cae2d26353","width":400,"height":225}},"href":"https://mma.prnewswire.com/media/2919932/ILLUMINA_INC__AGBT.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Unlocking the human genome has changed the face of cancer care and opened up demand for the next wave of biological insights," said Jacob Thaysen, chief executive officer at Illumina. "Researchers are rapidly adopting multiomics and informatics technologies that expand our understanding of biology at scale. Illumina's streamlined multiomics workflows are enabling customers to achieve game-changing breakthroughs in oncology, pharmacogenomics, and more."","length":481,"tagName":"p"},{"type":"text","content":"Illumina Spatial Technology decodes complex tissues with ease","length":61,"tagName":"p"},{"type":"text","content":"The human lymphatic system is notoriou...